$CHGA Income Statement | Understand Stock

$CHGA

$1.55 +$0.09 (6.16%) Close

$CHGA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Real property rental
Medical related consulting services - related party
Total Costs and Expenses
Gross profit from medical related consulting services
Total Gross Profit
REAL PROPERTY OPERATING EXPENSES
REAL PROPERTY OPERATING INCOME
INCOME (LOSS) FROM EQUITY METHOD INVESTMENT - LAB SERVICES MSO
OTHER OPERATING EXPENSES:
Advertising and marketing expenses
Professional fees
Compensation and related benefits
Research and development expenses
Litigation settlement
Other general and administrative expenses

Total Other Operating Expenses
LOSS FROM OPERATIONS
OTHER (EXPENSE) INCOME
Interest expense - other
Related Party
Total interest expense - other

Loss from equity method investment
Other income
Total Other Expense, net
Conversion inducement expense
Loss from equity method investment - Epicon
Interest expense - related party
Related Party
Total interest expense - related party
Debt modification charge
Change in fair value of derivative liability
Impairment of equity method investment - Epicon
Loss on extinguishment of debt
Other expense
Other income (expense)

Total Other Expense, net
LOSS BEFORE INCOME TAXES
NET LOSS FROM CONTINUING OPERATIONS
NET LOSS FROM DISCONTINUED OPERATIONS
NET LOSS
OTHER COMPREHENSIVE LOSS FROM CONTINUED OPERATIONS
Unrealized foreign currency translation gain
Unrealized foreign currency translation loss

COMPREHENSIVE LOSS
COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST
DEEMED CONTRIBUTION ON EXCHANGE OF EQUITY INSTRUMENTS
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:
Basic and diluted (in Dollars per share)
Basic, continuing operations (in Dollars per share)
Diluted, continuing operations (in Dollars per share)
Basic, discontinued operations (in Dollars per share)
Diluted, discontinued operations (in Dollars per share)
Net Loss Per Common Share Attributable Common Shareholders basic (in Dollars per share)
Net Loss Per Common Share Attributable Common Shareholders diluted (in Dollars per share)

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic and diluted (in Shares)
Weighted Average Common Shares Outstanding Basic (in Shares)
Weighted Average Common Shares Outstanding diluted (in Shares)

Comments